NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 760 filers reported holding NOVARTIS A G in Q2 2013. The put-call ratio across all filers is 0.60 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $8,000 | +300.0% | 90 | +246.2% | 0.00% | – |
| Q3 2015 | $2,000 | -99.7% | 26 | -99.6% | 0.00% | -100.0% |
| Q2 2015 | $655,000 | +7.9% | 6,662 | +8.2% | 0.06% | +3.6% |
| Q1 2015 | $607,000 | 0.0% | 6,155 | -6.0% | 0.06% | +83.3% |
| Q4 2014 | $607,000 | -2.3% | 6,547 | -0.8% | 0.03% | -3.2% |
| Q3 2014 | $621,000 | -8.0% | 6,601 | -11.5% | 0.03% | 0.0% |
| Q2 2014 | $675,000 | +2.3% | 7,461 | -3.9% | 0.03% | 0.0% |
| Q1 2014 | $660,000 | +0.8% | 7,767 | -4.6% | 0.03% | +3.3% |
| Q4 2013 | $655,000 | -97.8% | 8,145 | -97.9% | 0.03% | -96.6% |
| Q3 2013 | $29,925,000 | +6.2% | 390,111 | -2.1% | 0.88% | -34.3% |
| Q2 2013 | $28,171,000 | +6230.6% | 398,399 | +6275.4% | 1.34% | +6295.2% |
| Q1 2013 | $445,000 | +11.8% | 6,249 | -0.6% | 0.02% | +5.0% |
| Q4 2012 | $398,000 | +1.8% | 6,289 | -1.4% | 0.02% | +5.3% |
| Q3 2012 | $391,000 | – | 6,377 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |